TRIUMPH-4 and the Knee Osteoarthritis Surprise: What the First Phase 3 Retatrutide Trial Actually Showed
TRIUMPH-4 and the Knee Osteoarthritis Surprise: What the First Phase 3 Retatrutide Trial Actually Showed If you’ve struggled with knee pain alongside excess weight, the December 2025 TRIUMPH-4 results are the kind of data that turn heads. Participants on the highest dose of retatrutide lost an average of 28.7% of their body weight at 68 […]
What TRANSCEND-T2D-1 Tells Us About Retatrutide in Type 2 Diabetes
What TRANSCEND-T2D-1 Tells Us About Retatrutide in Type 2 Diabetes If you have type 2 diabetes and you’ve been watching the retatrutide story unfold, March 2026 was a milestone you probably noticed. Eli Lilly reported topline results from TRANSCEND-T2D-1 — the first Phase 3 retatrutide trial in adults with type 2 diabetes to read out. […]
TRIUMPH-1 Explained: What to Expect From Retatrutide’s Pivotal Phase 3 Obesity Readout
TRIUMPH-1 Explained: What to Expect From Retatrutide’s Pivotal Phase 3 Obesity Readout If you’ve been following retatrutide for months — refreshing news pages, tracking Eli Lilly’s pipeline updates, and waiting for the obesity numbers everyone keeps talking about — you’re not alone. The trial that will actually decide retatrutide’s case for FDA approval as a […]
Eli Lilly’s Q1 2026 Update on Retatrutide: What the Latest Earnings Call Tells Us About Approval Timing
Eli Lilly’s Q1 2026 Update on Retatrutide: What the Latest Earnings Call Tells Us About Approval Timing If you’ve been refreshing news pages every quarter trying to figure out when retatrutide is actually going to be available, the most useful single source isn’t a press release — it’s the earnings call transcript. That’s where Eli […]
What Is a Triple Agonist?
Learn what a triple agonist is, how it works, and why researchers are studying compounds like retatrutide. Clear, science-based explanation for beginners.
The Future of GLP-1, GIP, and Glucagon Drugs
Explore the future of obesity treatments with GLP-1, GIP, and glucagon drugs. Learn how investigational therapies like retatrutide fit into next-generation research.
Retatrutide vs Tirzepatide: What Users Need to Know
As interest in metabolic health and weight-related therapies grows, many people encounter two names early in their research: retatrutide and tirzepatide. While they are often mentioned together, they are not the same—and understanding the differences is important before drawing conclusions.